A novel COE-D8-fosfomycin conjugate effectively combats first-line antibiotic-resistant uropathogenic Escherichia coli
Lin Ruan, Cun Fan, Jingjie Chen, Yingxia Wang, Yuji Ren, Wenli Yuan, Xiaozhe Xiong, Chunming Guo · 2026
Read A novel COE-D8-fosfomycin conjugate effectively combats first-line antibiotic-resistant uropathogenic Escherichia coli by Lin Ruan, Cun Fan, Jingjie Chen, Yingxia Wang, Yuji Ren, Wenli Yuan, Xiaozhe Xiong, Chunming Guo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0352997.txt.
Description
Lin Ruan and seven colleagues present this 2026 PLOS One laboratory study of a new weapon against drug-resistant urinary tract infections. The bacteria behind most such infections increasingly shrug off first-line antibiotics. The team tested a membrane-attacking compound called COE-D8 against ninety-three clinical samples of uropathogenic E. coli, most of which resisted standard drugs at high doses.
Nearly all the samples stayed sensitive to the new compound, which killed bacteria several times faster than standard antibiotics by tearing their membranes. Because the compound alone can harm host cells, the team paired it with the antibiotic fosfomycin, which lowered the needed dose and doubled survival in a mouse safety model. Bacteria also struggled to evolve resistance, supporting the pair as a candidate for stubborn infections.
Catalog record
| CREATOR | Lin Ruan, Cun Fan, Jingjie Chen, Yingxia Wang, Yuji Ren, Wenli Yuan, Xiaozhe Xiong, Chunming Guo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40015 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |